$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

경두개 직류 자극-정신과적 활용과 현황
Transcranial Direct Current Stimulation-Psychiatric Application and Its Current Status 원문보기

생물정신의학 = Korean journal of biological psychiatry, v.24 no.4, 2017년, pp.175 - 187  

김평규 ((주)와이브레인 기업부설 연구소) ,  김도형 ((주)와이브레인 기업부설 연구소)

Abstract AI-Helper 아이콘AI-Helper

Transcranial direct current stimulation (TDCS) is a clinically safe and effective method of delivering weak electric current to modulate cortical activities. And based on the cumulating scientific evidences, the method is recommended to treat major depressive disorder (MDD) and other psychiatric dis...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • 12) 본 종설에서는 TDCS기술에 대한 원리와 장단점을 소개하며, TDCS 기술을 활용한 대표적인 정신과 질환에 대한 최근까지의 연구결과와 치료 및 개선 원리에 대해 다뤄 보고자 한다.

가설 설정

  • 29) 한편으로 시냅스 형성에 미세관(microtubule)이 중요한 역할을 하는 것으로 알려져 있으며,30) TDCS 자극에 의해서 시냅스 형성이 영향을 받는 것 또한 알려진 사실이다. 흥미롭게도 초음파 자극의 주된 가설로 미세관 공진(resonant vibration) 현상이 존재하는데,3) 이 가설은 미세관 활동 조절이 시냅스 형성과 신경 활동에 영향을 준다는 것이다.31)32)
본문요약 정보가 도움이 되었나요?

질의응답

핵심어 질문 논문에서 추출한 답변
TDCS란 무엇인가? TDCS는 패치 형태의 양극(anodal electrode)과 음극(cathodal electrode)을 두피에 부착하고, 비-침습적으로 일정한 전류(electric current)를 흐르게 하여, 뇌 활동에 영향을 주는 뇌 자극(brain stimulation) 방법이다.12) 본 종설에서는 TDCS기술에 대한 원리와 장단점을 소개하며, TDCS 기술을 활용한 대표적인 정신과 질환에 대한 최근까지의 연구결과와 치료 및 개선 원리에 대해 다뤄 보고자 한다.
Buzsaki 그룹의 사체연구에 따르면 TDCS의 한계점은 무엇인가? 29 mA/cm2보다 훨씬 낮은 수준이지만, 뇌 활동에 영향을 줄 만한 수준의 전류밀도로 알려져 있다.17) 한편으로 최근 Buzsaki 그룹의 사체연구(cadaver study)에 따르면, 적용되는 전류의 90%가 피부를 통해서 빠져나가 대뇌피질에 충분히 도달하지 못한다는 결과를 제시했으며, 살아 있는 인체에는 전류의 누수 현상(shunting effect)이 더 클 것으로 보았다. 물론 사후 검증의 한계와 고려하지 못한 환경적 요인에 의한 가능성이 있으므로, 심도 있는 추가 실험이 필요하다.
현재까지 알려진 가장 유력한 TDCS의 작용 원리는 무엇인가? 현재까지 알려진 가장 유력한 TDCS의 작용 원리는 인가된 전류에 의해 발생된 전기 자극에 의해서, 생체 조직의 전위 변화가 피질 신경세포들의 휴지전위(resting potential)에 미세한 영향을 주게 되며,25) 이로 인한 신경세포의 자발적 방전율(spontaneous discharge rate)을 변화시키는 것으로 알려져 있다.19) TDCS의 양극 자극(anodal stimulation)을 가해 대뇌피질의 휴지전위를 역치 전위(action potential)에 가깝게함으로, 신경세포들의 활성도가 증가하는 것으로 알려져 있다.
질의응답 정보가 도움이 되었나요?

참고문헌 (178)

  1. Luan S, Williams I, Nikolic K, Constandinou TG. Neuromodulation: present and emerging methods. Front Neuroeng 2014;7:27. 

  2. Tyler WJ. Noninvasive neuromodulation with ultrasound? A continuum mechanics hypothesis. Neuroscientist 2011;17:25-36. 

  3. Hameroff S, Trakas M, Duffield C, Annabi E, Gerace MB, Boyle P, et al. Transcranial ultrasound (TUS) effects on mental states: a pilot study. Brain Stimul 2013;6:409-415. 

  4. Jang C, Park HJ, Chang WS, Pae C, Chang JW. Immediate and longitudinal alterations of functional networks after thalamotomy in essential tremor. Front Neurol 2016;7:184. 

  5. Yoo SS, Bystritsky A, Lee JH, Zhang Y, Fischer K, Min BK, et al. Focused ultrasound modulates region-specific brain activity. Neuroimage 2011;56:1267-1275. 

  6. Huhn M, Tardy M, Spineli LM, Kissling W, Forstl H, Pitschel-Walz G, et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses. JAMA Psychiatry 2014;71:706-715. 

  7. Hollis C, Morriss R, Martin J, Amani S, Cotton R, Denis M, et al. Technological innovations in mental healthcare: harnessing the digital revolution. Br J Psychiatry 2015;206:263-265. 

  8. Hasey GM. Transcranial magnetic stimulation: using a law of physics to treat psychopathology. J Psychiatry Neurosci 1999;24:97-101. 

  9. Pascual-Leone A, Rubio B, Pallardo F, Catala MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996;348:233-237. 

  10. Leiknes KA, Cooke MJ, Jarosch-von Schweder L, Harboe I, Hoie B. Electroconvulsive therapy during pregnancy: a systematic review of case studies. Arch Womens Ment Health 2015;18:1-39. 

  11. Fregni F, Nitsche MA, Loo CK, Brunoni AR, Marangolo P, Leite J, et al. Regulatory considerations for the clinical and research use of transcranial direct current stimulation (tDCS): review and recommendations from an expert panel. Clin Res Regul Aff 2015;32:22-35. 

  12. Zaghi S, Acar M, Hultgren B, Boggio PS, Fregni F. Noninvasive brain stimulation with low-intensity electrical currents: putative mechanisms of action for direct and alternating current stimulation. Neuroscientist 2010;16:285-307. 

  13. Priori A, Hallett M, Rothwell JC. Repetitive transcranial magnetic stimulation or transcranial direct current stimulation? Brain Stimul 2009;2:241-245. 

  14. Nitsche MA, Boggio PS, Fregni F, Pascual-Leone A. Treatment of depression with transcranial direct current stimulation (tDCS): a review. Exp Neurol 2009;219:14-19. 

  15. Kim JW, Lee J. Application of transcranial direct current stimulation in psychiatry. J Korean Neuropsychiatr Assoc 2016;55:158-167. 

  16. Wagner T, Fregni F, Fecteau S, Grodzinsky A, Zahn M, Pascual-Leone A. Transcranial direct current stimulation: a computer-based human model study. Neuroimage 2007;35:1113-1124. 

  17. Bikson M, Datta A, Elwassif M. Establishing safety limits for transcranial direct current stimulation. Clin Neurophysiol 2009;120:1033-1034. 

  18. Underwood E. NEUROSCIENCE. Cadaver study challenges brain stimulation methods. Science 2016;352:397. 

  19. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 2000;527 Pt 3:633-639. 

  20. Bikson M, Grossman P, Thomas C, Zannou AL, Jiang J, Adnan T, et al. Safety of transcranial direct current stimulation: evidence based update 2016. Brain Stimulation 2016;9:641-661. 

  21. Brunoni AR, Amadera J, Berbel B, Volz MS, Rizzerio BG, Fregni F. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int J Neuropsychopharmacol 2011;14:1133-1145. 

  22. Kessler SK, Turkeltaub PE, Benson JG, Hamilton RH. Differences in the experience of active and sham transcranial direct current stimulation. Brain Stimul 2012;5:155-162. 

  23. Brunoni A, Loo C, Nitsche M. Safety and tolerability. In: Brunoni A, Nitsche M, Loo C, editors. Transcranial Direct Current Stimulation in Neuropsychiatric Disorders. 1st ed. Cham: Springer;2016. p.343-350. 

  24. Matsumoto H, Ugawa Y. Adverse events of tDCS and tACS: a review. Clin Neurophysiol Pract 2017;2:19-25. 

  25. Bindman LJ, Lippold OC, Redfearn JW. Long-lasting changes in the level of the electrical activity of the cerebral cortex produced bypolarizing currents. Nature 1962;196:584-585. 

  26. Rahman A, Reato D, Arlotti M, Gasca F, Datta A, Parra LC, et al. Cellular effects of acute direct current stimulation: somatic and synaptic terminal effects. J Physiol 2013;591:2563-2578. 

  27. Paulus W. Transcranial electrical stimulation (tES-tDCS; tRNS, tACS) methods. Neuropsychol Rehabil 2011;21:602-617. 

  28. Liebetanz D, Nitsche MA, Tergau F, Paulus W. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain 2002;125:2238-2247. 

  29. Podda MV, Cocco S, Mastrodonato A, Fusco S, Leone L, Barbati SA, et al. Anodal transcranial direct current stimulation boosts synaptic plasticity and memory in mice via epigenetic regulation of Bdnf expression. Sci Rep 2016;6:22180. 

  30. Pelletier SJ, Cicchetti F. Cellular and molecular mechanisms of action of transcranial direct current stimulation: evidence from in vitro and in vivo models. Int J Neuropsychopharmacol 2015;18:pyu047. 

  31. Okamoto K, Bosch M, Hayashi Y. The roles of CaMKII and F-actin in the structural plasticity of dendritic spines: a potential molecular identity of a synaptic tag? Physiology (Bethesda) 2009;24:357-366. 

  32. Dent EW, Baas PW. Microtubules in neurons as information carriers. J Neurochem 2014;129:235-239. 

  33. Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012;64:238-258. 

  34. Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS, et al. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet 2006;141B:387-393. 

  35. Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, et al. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression. Neurobiol Aging 2009;30:1406-1412. 

  36. Monai H, Ohkura M, Tanaka M, Oe Y, Konno A, Hirai H, et al. Calcium imaging reveals glial involvement in transcranial direct current stimulation-induced plasticity in mouse brain. Nat Commun 2016;7:11100. 

  37. Araque A, Navarrete M. Glial cells in neuronal network function. Philos Trans R Soc Lond B Biol Sci 2010;365:2375-2381. 

  38. Radman T, Ramos RL, Brumberg JC, Bikson M. Role of cortical cell type and morphology in subthreshold and suprathreshold uniform electric field stimulation in vitro. Brain Stimul 2009;2:215-228, 228.e1-e3. 

  39. Hummel FC, Celnik P, Pascual-Leone A, Fregni F, Byblow WD, Buetefisch CM, et al. Controversy: Noninvasive and invasive cortical stimulation show efficacy in treating stroke patients. Brain Stimul 2008;1:370-382. 

  40. Chervyakov AV, Chernyavsky AY, Sinitsyn DO, Piradov MA. Possible mechanisms underlying the therapeutic effects of transcranial magnetic stimulation. Front Hum Neurosci 2015;9:303. 

  41. Costain R, Redfearn JW, Lippold OC. A controlled trial of the therapeutic effect of polarization of the brain in depressive illness. Br J Psychiatry 1964;110:786-799. 

  42. Redfearn JW, Lippold OC, Costain R. A preliminary account of the clinical effects of polarizing the brain in certain psychiatric disorders. Br J Psychiatry 1964;110:773-785. 

  43. Moffa AH, Valiengo L, Shiozawa P, Brunoni AR. Novel neurotherapeutics in psychiatry: use and rationale of transcranial direct current stimulation in major depressive disorder. Rev Psiquiatr Clin 2014;41:15-20. 

  44. Au J, Katz B, Buschkuehl M, Bunarjo K, Senger T, Zabel C, et al. Enhancing working memory training with transcranial direct current stimulation. J Cogn Neurosci 2016;28:1419-1432. 

  45. Coffman BA, Clark VP, Parasuraman R. Battery powered thought: enhancement of attention, learning, and memory in healthy adults using transcranial direct current stimulation. Neuroimage 2014;85 Pt 3:895-908. 

  46. Ehsani F, Bakhtiary AH, Jaberzadeh S, Talimkhani A, Hajihasani A. Differential effects of primary motor cortex and cerebellar transcranial direct current stimulation on motor learning in healthy individ uals: a randomized double-blind sham-controlled study. Neurosci Res 2016;112:10-19. 

  47. Brunoni AR, Nitsche MA, Bolognini N, Bikson M, Wagner T, Merabet L, et al. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul 2012;5:175-195. 

  48. Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 2016;22:238-249. 

  49. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008;455:894-902. 

  50. Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat Med 2001;7:541-547. 

  51. Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F, et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry 2008;63:369-376. 

  52. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008;213:93-118. 

  53. Brunoni AR, Valiengo L, Baccaro A, Zanao TA, de Oliveira JF, Vieira GP, et al. Sertraline vs. eLectrical current therapy for treating depression clinical trial--SELECT TDCS: design, rationale and objectives. Contemp Clin Trials 2011;32:90-98. 

  54. Brunoni AR, Valiengo L, Baccaro A, Zanao TA, de Oliveira JF, Goulart A, et al. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry 2013;70:383-391. 

  55. Gandiga PC, Hummel FC, Cohen LG. Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulation. Clin Neurophysiol 2006;117:845-850. 

  56. Rigonatti SP, Boggio PS, Myczkowski ML, Otta E, Fiquer JT, Ribeiro RB, et al. Transcranial direct stimulation and fluoxetine for the treatment of depression. Eur Psychiatry 2008;23:74-76. 

  57. Dedoncker J, Brunoni AR, Baeken C6, Vanderhasselt MA. The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis. J Neural Transm (Vienna) 2016;123:1159-1172. 

  58. Mulquiney PG, Hoy KE, Daskalakis ZJ, Fitzgerald PB. Improving working memory: exploring the effect of transcranial random noise stimulation and transcranial direct current stimulation on the dorsolateral prefrontal cortex. Clin Neurophysiol 2011;122:2384-2389. 

  59. Ohn SH, Park CI, Yoo WK, Ko MH, Choi KP, Kim GM, et al. Timedependent effect of transcranial direct current stimulation on the enhancement of working memory. Neuroreport 2008;19:43-47. 

  60. Boggio PS, Bermpohl F, Vergara AO, Muniz AL, Nahas FH, Leme PB, et al. Go-no-go task performance improvement after anodal transcranial DC stimulation of the left dorsolateral prefrontal cortex in major depression. J Affect Disord 2007;101:91-98. 

  61. Wolkenstein L, Plewnia C. Amelioration of cognitive control in depression by transcranial direct current stimulation. Biol Psychiatry 2013;73:646-651. 

  62. Blumberger DM, Tran LC, Fitzgerald PB, Hoy KE, Daskalakis ZJ. A randomized double-blind sham-controlled study of transcranial direct current stimulation for treatment-resistant major depression. Front Psychiatry 2012;3:74. 

  63. Lefaucheur JP, Antal A, Ayache SS, Benninger DH, Brunelin J, Cogiamanian F, et al. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol 2017;128:56-92. 

  64. Loo CK, Sachdev P, Martin D, Pigot M, Alonzo A, Malhi GS, et al. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol 2010;13:61-69. 

  65. Fregni F, Boggio PS, Nitsche MA, Marcolin MA, Rigonatti SP, Pascual-Leone A. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord 2006;8:203-204. 

  66. Berlim MT, Van den Eynde F, Daskalakis ZJ. Clinical utility of transcranial direct current stimulation (tDCS) for treating major depression: a systematic review and meta-analysis of randomized, doubleblind and sham-controlled trials. J Psychiatr Res 2013;47:1-7. 

  67. Kalu UG, Sexton CE, Loo CK, Ebmeier KP. Transcranial direct current stimulation in the treatment of major depression: a meta-analysis. Psychol Med 2012;42:1791-1800. 

  68. Valiengo L, Bensenor IM, Goulart AC, de Oliveira JF, Zanao TA, Boggio PS, et al. The sertraline versus electrical current therapy for treating depression clinical study (select-TDCS): results of the crossover and follow-up phases. Depress Anxiety 2013;30:646-653. 

  69. Shiozawa P, Fregni F, Bensenor IM, Lotufo PA, Berlim MT, Daskalakis JZ, et al. Transcranial direct current stimulation for major depression: an updated systematic review and meta-analysis. Int J Neuropsychopharmacol 2014;17:1443-1452. 

  70. Brunoni AR, Moffa AH, Fregni F, Palm U, Padberg F, Blumberger DM, et al. Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data. Br J Psychiatry 2016;208:522-531. 

  71. Vigod S, Dennis CL, Daskalakis Z, Murphy K, Ray J, Oberlander T, et al. Transcranial direct current stimulation (tDCS) for treatment of major depression during pregnancy: study protocol for a pilot randomized controlled trial. Trials 2014;15:366. 

  72. Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004;161:1-56. 

  73. Alonzo A, Aaronson S, Bikson M, Husain M, Lisanby S, Martin D, et al. Study design and methodology for a multicentre, randomised controlled trial of transcranial direct current stimulation as a treatment for unipolar and bipolar depression. Contemp Clin Trials 2016;51:65-71. 

  74. Brunoni AR, Ferrucci R, Bortolomasi M, Vergari M, Tadini L, Boggio PS, et al. Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:96-101. 

  75. Brunoni AR, Moffa AH, Sampaio-Junior B, Galvez V, Loo CK. Treatment-emergent mania/hypomania during antidepressant treatment with transcranial direct current stimulation (tDCS): a systematic review and meta-analysis. Brain Stimul 2017;10:260-262. 

  76. Pereira Junior Bde S, Tortella G, Lafer B, Nunes P, Bensenor IM, Lotufo PA, et al. The bipolar depression electrical treatment trial (BETTER): design, rationale, and objectives of a randomized, shamcontrolled trial and data from the pilot study phase. Neural Plast 2015;2015:684025. 

  77. Green IW, Glausier JR. Different paths to core pathology: the equifinal model of the schizophrenia syndrome. Schizophr Bull 2016;42:542-549. 

  78. Lewis DA, Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002;25:409-432. 

  79. Pulver AE. Search for schizophrenia susceptibility genes. Biol Psychiatry 2000;47:221-230. 

  80. Lewis DA, Lieberman JA. Catching up on schizophrenia: natural history and neurobiology. Neuron 2000;28:325-334. 

  81. Rajji TK, Ismail Z, Mulsant BH. Age at onset and cognition in schizophrenia: meta-analysis. Br J Psychiatry 2009;195:286-293. 

  82. Riglin L, Collishaw S, Richards A, Thapar AK, Maughan B, O'Donovan MC, et al. Schizophrenia risk alleles and neurodevelopmental outcomes in childhood: a population-based cohort study. Lancet Psychiatry 2017;4:57-62. 

  83. Lefebvre S, Demeulemeester M, Leroy A, Delmaire C, Lopes R, Pins D, et al. Network dynamics during the different stages of hallucinations in schizophrenia. Hum Brain Mapp 2016;37:2571-2586. 

  84. Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006;60:132-140. 

  85. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 2003;8:592-610. 

  86. Kendler KS. A joint history of the nature of genetic variation and the nature of schizophrenia. Mol Psychiatry 2015;20:77-83. 

  87. Straub RE, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, et al. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat Genet 1995;11:287-293. 

  88. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008;320:539-543. 

  89. Siekmeier PJ, vanMaanen DP. Dopaminergic contributions to hippocampal pathophysiology in schizophrenia: a computational study. Neuropsychopharmacology 2014;39:1713-1721. 

  90. Johnsen MS. Aspects of the NMDA receptor hypofunction hypothesis of schizophrenia : Neurobiology in schizophrenia [dissertation]. Oslo: University of Oslo;2011. 

  91. O'Connor WT, O'Shea SD. Clozapine and GABA transmission in schizophrenia disease models: establishing principles to guide treatments. Pharmacol Ther 2015;150:47-80. 

  92. Schwartz TL, Sachdeva S, Stahl SM. Glutamate neurocircuitry: theoretical underpinnings in schizophrenia. Front Pharmacol 2012;3:195. 

  93. Kim DH, Stahl SM. Antipsychotic drug development. In: Swerdlow NR, editors. Behavioral Neurobiology of Schizophrenia and Its Treatment. 1st ed. New York, NY: Springer;2010. P.123-139. 

  94. Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet 2013;382:951-962. 

  95. Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 4th ed. Cambridge: Cambridge University Press;2013. 

  96. Andersen SL. Commentary on the special issue on the adolescent brain: Adolescence, trajectories, and the importance of prevention. Neurosci Biobehav Rev 2016;70:329-333. 

  97. Giovanoli S, Engler H, Engler A, Richetto J, Feldon J, Riva MA, et al. Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia. Transl Psychiatry 2016;6:e772. 

  98. Moritz S, Andreou C, Klingberg S, Thoering T, Peters MJ. Assessment of subjective cognitive and emotional effects of antipsychotic drugs. Effect by defect? Neuropharmacology 2013;72:179-186. 

  99. Cole JC, Green Bernacki C, Helmer A, Pinninti N, O'reardon JP. Efficacy of transcranial magnetic stimulation (TMS) in the treatment of schizophrenia: a review of the literature to date. Innov Clin Neurosci 2015;12:12-19. 

  100. Slotema CW, Aleman A, Daskalakis ZJ, Sommer IE. Meta-analysis of repetitive transcranial magnetic stimulation in the treatment of auditory verbal hallucinations: update and effects after one month. Schizophr Res 2012;142:40-45. 

  101. Aleman A, Sommer IE, Kahn RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin Psychiatry 2007;68:416-421. 

  102. d'Alfonso AA, Aleman A, Kessels RP, Schouten EA, Postma A, van Der Linden JA, et al. Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition. J Neuropsychiatry Clin Neurosci 2002;14:77-79. 

  103. Lee SH, Kim W, Chung YC, Jung KH, Bahk WM, Jun TY, et al. A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett 2005;376:177-181. 

  104. Stanford AD, Sharif Z, Corcoran C, Urban N, Malaspina D, Lisanby SH. rTMS strategies for the study and treatment of schizophrenia: a review. Int J Neuropsychopharmacol 2008;11:563-576. 

  105. Arumugham SS, Thirthalli J, Andrade C. Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia. Expert Rev Clin Pharmacol 2016;9:1245-1252. 

  106. George MS, Aston-Jones G. Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology 2010;35:301-316. 

  107. Minzenberg MJ, Carter CS. Developing treatments for impaired cognition in schizophrenia. Trends Cogn Sci 2012;16:35-42. 

  108. Shergill SS, Murray RM, McGuire PK. Auditory hallucinations: a review of psychological treatments. Schizophr Res 1998;32:137-150. 

  109. Lawrie SM, Buechel C, Whalley HC, Frith CD, Friston KJ, Johnstone EC. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biol Psychiatry 2002;51:1008-1011. 

  110. Jardri R, Pouchet A, Pins D, Thomas P. Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinatebased meta-analysis. Am J Psychiatry 2011;168:73-81. 

  111. Brunelin J, Mondino M, Gassab L, Haesebaert F, Gaha L, Suaud- Chagny MF, et al. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry 2012;169:719-724. 

  112. Shiozawa P, da Silva ME, Cordeiro Q, Fregni F, Brunoni AR. Transcranial direct current stimulation (tDCS) for the treatment of persistent visual and auditory hallucinations in schizophrenia: a case study. Brain Stimul 2013;6:831-833. 

  113. Andrade C. Once- to twice-daily, 3-year domiciliary maintenance transcranial direct current stimulation for severe, disabling, clozapine-refractory continuous auditory hallucinations in schizophrenia. J ECT 2013;29:239-242. 

  114. Mondino M, Haesebaert F, Poulet E, Suaud-Chagny MF, Brunelin J. Fronto-temporal transcranial direct current stimulation (tDCS) reduces source-monitoring deficits and auditory hallucinations in patients with schizophrenia. Schizophr Res 2015;161:515-516. 

  115. Mondino M, Jardri R, Suaud-Chagny MF, Saoud M, Poulet E, Brunelin J. Effects of fronto-temporal transcranial direct current stimulation on auditory verbal hallucinations and resting-state functional connectivity of the left temporo-parietal junction in patients with schizophrenia. Schizophr Bull 2016;42:318-326. 

  116. Fitzgerald PB, McQueen S, Daskalakis ZJ, Hoy KE. A negative pilot study of daily bimodal transcranial direct current stimulation in schizophrenia. Brain Stimul 2014;7:813-816. 

  117. Frohlich F, Burrello TN, Mellin JM, Cordle AL, Lustenberger CM, Gilmore JH, et al. Exploratory study of once-daily transcranial direct current stimulation (tDCS) as a treatment for auditory hallucinations in schizophrenia. Eur Psychiatry 2016;33:54-60. 

  118. Palm U, Keeser D, Hasan A, Kupka MJ, Blautzik J, Sarubin N, et al. Prefrontal transcranial direct current stimulation for treatment of schizophrenia with predominant negative symptoms: a doubleblind, sham-controlled proof-of-concept study. Schizophr Bull 2016;42:1253-1261. 

  119. Smith RC, Boules S, Mattiuz S, Youssef M, Tobe RH, Sershen H, et al. Effects of transcranial direct current stimulation (tDCS) on cognition, symptoms, and smoking in schizophrenia: A randomized controlled study. Schizophr Res 2015;168:260-266. 

  120. Gomes JS, Shiozawa P, Dias AM, Valverde Ducos D, Akiba H, Trevizol AP, et al. Left dorsolateral prefrontal cortex anodal tDCS effects on negative symptoms in schizophrenia. Brain Stimul 2015;8:989-991. 

  121. Mattai A, Miller R, Weisinger B, Greenstein D, Bakalar J, Tossell J, et al. Tolerability of transcranial direct current stimulation in childhood-onset schizophrenia. Brain Stimul 2011;4:275-280. 

  122. Rassovsky Y, Dunn W, Wynn J, Wu AD, Iacoboni M, Hellemann G, et al. The effect of transcranial direct current stimulation on social cognition in schizophrenia: A preliminary study. Schizophr Res 2015;165:171-174. 

  123. Dani JA, Jenson D, Broussard JI, De Biasi M. Neurophysiology of nicotine addiction. J Addict Res Ther 2011;S1. pii: 001. 

  124. Volkow ND, Wang GJ, Tomasi D, Baler RD. Unbalanced neuronal circuits in addiction. Curr Opin Neurobiol 2013;23:639-648. 

  125. Volkow ND, Baler RD. Addiction science: uncovering neurobiological complexity. Neuropharmacology 2014;76 Pt B:235-249. 

  126. Gowin JL, Mackey S, Paulus MP. Altered risk-related processing in substance users: imbalance of pain and gain. Drug Alcohol Depend 2013;132:13-21. 

  127. Hone-Blanchet A, Fecteau S. The use of non-invasive brain stimulation in drug addictions. In: Kadosh RC, editors. The Stimulated Brain: Cognitive Enhancement Using Non-Invasive Brain Stimulation. Oxford: Elsevier;2014. p.425. 

  128. Bellamoli E, Manganotti P, Schwartz RP, Rimondo C, Gomma M, Serpelloni G. rTMS in the treatment of drug addiction: an update about human studies. Behav Neurol 2014;2014:815215. 

  129. Yavari F, Shahbabaie A, Leite J, Carvalho S, Ekhtiari H, Fregni F. Noninvasive brain stimulation for addiction medicine: from monitoring to modulation. Prog Brain Res 2016;224:371-399. 

  130. Rachid F. Neurostimulation techniques in the treatment of nicotine dependence: a review. Am J Addict 2016;25:436-451. 

  131. Boggio PS, Sultani N, Fecteau S, Merabet L, Mecca T, Pascual-Leone A, et al. Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: a double-blind, sham-controlled study. Drug Alcohol Depend 2008;92:55-60. 

  132. Weber MJ, Messing SB, Rao H, Detre JA, Thompson-Schill SL. Prefrontal transcranial direct current stimulation alters activation and connectivity in cortical and subcortical reward systems: a tDCSfMRI study. Hum Brain Mapp 2014;35:3673-3686. 

  133. Mishra BR, Praharaj SK, Katshu MZ, Sarkar S, Nizamie SH. Comparison of anticraving efficacy of right and left repetitive transcranial magnetic stimulation in alcohol dependence: a randomized double-blind study. J Neuropsychiatry Clin Neurosci 2015;27:e54-e59. 

  134. Klauss J, Penido Pinheiro LC, Silva Merlo BL, de Almeida Correia Santos G, Fregni F, Nitsche MA, et al. A randomized controlled trial of targeted prefrontal cortex modulation with tDCS in patients with alcohol dependence. Int J Neuropsychopharmacol 2014;17:1793-1803. 

  135. Batista EK, Klauss J, Fregni F, Nitsche MA, Nakamura-Palacios EM. A randomized placebo-controlled trial of targeted prefrontal cortex modulation with bilateral tDCS in patients with crack-cocaine dependence. Int J Neuropsychopharmacol 2015;18. pii: pyv066. 

  136. Boggio PS, Liguori P, Sultani N, Rezende L, Fecteau S, Fregni F. Cumulative priming effects of cortical stimulation on smoking cue-induced craving. Neurosci Lett 2009;463:82-86. 

  137. Jansen JM, Daams JG, Koeter MW, Veltman DJ, van den Brink W, Goudriaan AE. Effects of non-invasive neurostimulation on craving: a meta-analysis. Neurosci Biobehav Rev 2013;37:2472-2480. 

  138. Boggio PS, Zaghi S, Villani AB, Fecteau S, Pascual-Leone A, Fregni F. Modulation of risk-taking in marijuana users by transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC). Drug Alcohol Depend 2010;112:220-225. 

  139. Shahbabaie A, Golesorkhi M, Zamanian B, Ebrahimpoor M, Keshvari F, Nejati V, et al. State dependent effect of transcranial direct current stimulation (tDCS) on methamphetamine craving. Int J Neuropsychopharmacol 2014;17:1591-1598. 

  140. Goldman RL, Borckardt JJ, Frohman HA, O'Neil PM, Madan A, Campbell LK, et al. Prefrontal cortex transcranial direct current stimulation (tDCS) temporarily reduces food cravings and increases the self-reported ability to resist food in adults with frequent food craving. Appetite 2011;56:741-746. 

  141. de Wit SJ, de Vries FE, van der Werf YD, Cath DC, Heslenfeld DJ, Veltman EM, et al. Presupplementary motor area hyperactivity during response inhibition: a candidate endophenotype of obsessive-compulsive disorder. Am J Psychiatry 2012;169:1100-1108. 

  142. Eddy KT, Dutra L, Bradley R, Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessivecompulsive disorder. Clin Psychol Rev 2004;24:1011-1030. 

  143. Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004;292:1969-1976. 

  144. Abelson JL, Curtis GC, Sagher O, Albucher RC, Harrigan M, Taylor SF, et al. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry 2005;57:510-516. 

  145. Ruffini C, Locatelli M, Lucca A, Benedetti F, Insacco C, Smeraldi E. Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation. Prim Care Companion J Clin Psychiatry 2009;11:226-230. 

  146. Posner J, Marsh R, Maia TV, Peterson BS, Gruber A, Simpson HB. Reduced functional connectivity within the limbic cortico-striatothalamo-cortical loop in unmedicated adults with obsessive-compulsive disorder. Hum Brain Mapp 2014;35:2852-2860. 

  147. Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci 2014;15:410-424. 

  148. Berlim MT, Neufeld NH, Van den Eynde F. Repetitive transcranial magnetic stimulation (rTMS) for obsessive-compulsive disorder (OCD): an exploratory meta-analysis of randomized and shamcontrolled trials. J Psychiatr Res 2013;47:999-1006. 

  149. D'Urso G, Brunoni AR, Mazzaferro MP, Anastasia A, de Bartolomeis A, Mantovani A. Transcranial direct current stimulation for obsessive-compulsive disorder: a randomized, controlled, partial crossover trial. Depress Anxiety 2016;33:1132-1140. 

  150. Goncalves OF, Carvalho S, Leite J, Pocinho F, Relvas J, Fregni F. Obsessive compulsive disorder as a functional interhemispheric imbalance at the thalamic level. Med Hypotheses 2011;77:445-447. 

  151. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 2005;57:1215-1220. 

  152. Sagvolden T, Johansen EB, Aase H, Russell VA. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 2005;28:397-419; discussion 419-468. 

  153. Kuczenski R, Segal DS. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 2001;296:876-883. 

  154. Solanto MV. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 2002;130:65-71. 

  155. Frodl T, Skokauskas N. Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand 2012;125:114-126. 

  156. Cortese S, Kelly C, Chabernaud C, Proal E, Di Martino A, Milham MP, et al. Toward systems neuroscience of ADHD: a metaanalysis of 55 fMRI studies. Am J Psychiatry 2012;169:1038-1055. 

  157. Bloch Y, Harel EV, Aviram S, Govezensky J, Ratzoni G, Levkovitz Y. Positive effects of repetitive transcranial magnetic stimulation on attention in ADHD subjects: a randomized controlled pilot study. World J Biol Psychiatry 2010;11:755-758. 

  158. Cachoeira CT, Leffa DT, Mittelstadt SD, Mendes LST, Brunoni AR, Pinto JV, et al. Positive effects of transcranial direct current stimulation in adult patients with attention-deficit/hyperactivity disorder-a pilot randomized controlled study. Psychiatry Res 2017;247:28-32. 

  159. Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 2013;70:185-198. 

  160. Soff C, Sotnikova A, Christiansen H, Becker K, Siniatchkin M. Transcranial direct current stimulation improves clinical symptoms in adolescents with attention deficit hyperactivity disorder. J Neural Transm (Vienna) 2017;124:133-144. 

  161. Margolis A, Milham MP. 44.0 neural circuitry underlying three common and often co-occurring childhood disorders: autism spectrum disorder, attention-deficit/hyperactivity disorder, and learning disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2016;55:S328. 

  162. Herbert MR, Harris GJ, Adrien KT, Ziegler DA, Makris N, Kennedy DN, et al. Abnormal asymmetry in language association cortex in autism. Ann Neurol 2002;52:588-596. 

  163. Floris DL, Chura LR, Holt RJ, Suckling J, Bullmore ET, Baron-Cohen S, et al. Psychological correlates of handedness and corpus callosum asymmetry in autism: the left hemisphere dysfunction theory revisited. J Autism Dev Disord 2013;43:1758-1772. 

  164. Kleinhans NM, Muller RA, Cohen DN, Courchesne E. Atypical functional lateralization of language in autism spectrum disorders. Brain Res 2008;1221:115-125. 

  165. Amatachaya A, Jensen MP, Patjanasoontorn N, Auvichayapat N, Suphakunpinyo C, Janjarasjitt S, et al. The short-term effects of transcranial direct current stimulation on electroencephalography in children with autism: a randomized crossover controlled trial. Behav Neurol 2015;2015:928631. 

  166. Kuo HI, Bikson M, Datta A, Minhas P, Paulus W, Kuo MF, et al. Comparing cortical plasticity induced by conventional and highdefinition 4 $\times$ 1 ring tDCS: a neurophysiological study. Brain stimulation 2013;6:644-648. 

  167. Edwards D, Cortes M, Datta A, Minhas P, Wassermann EM, Bikson M. Physiological and modeling evidence for focal transcranial electrical brain stimulation in humans: a basis for high-definition tDCS. Neuroimage 2013;74:266-275. 

  168. Ruffini G, Mateu OR, Pascual-Leone A, Fox MD, Miranda PMC. Method and a system for optimizing the configuration of multisite transcranial current stimulation and a computer-readable medium. Barcelona S.L.: Neuroelectrics;2013. 

  169. Castillo-Saavedra L, Gebodh N, Bikson M, Diaz-Cruz C, Brandao R, Coutinho L, et al. Clinically effective treatment of fibromyalgia pain with high-definition transcranial direct current stimulation: phase II open-label dose optimization. J Pain 2016;17:14-26. 

  170. Geva AB, Stern Y, Reches A. Neurophysiological data analysis using spatiotemporal parcellation. Herzliya: Elminda Ltd.;2013. 

  171. Paulus W, Nitsche MA, Antal A. Application of transcranial electric stimulation (tDCS, tACS, tRNS): From motor-evoked potentials towards modulation of behaviour. European Psychologist 2016;21:4-14. 

  172. Dimov LF, Franciosi AC, Campos AC, Brunoni AR, Pagano RL. Top-down effect of direct current stimulation on the nociceptive response of rats. PLoS One 2016;11:e0153506. 

  173. Taylor AG, Goehler LE, Galper DI, Innes KE, Bourguignon C. Top-down and bottom-up mechanisms in mind-body medicine: development of an integrative framework for psychophysiological research. Explore (NY) 2010;6:29-41. 

  174. Tyler WJ, Boasso AM, Mortimore HM, Silva RS, Charlesworth JD, Marlin MA, et al. Transdermal neuromodulation of noradrenergic activity suppresses psychophysiological and biochemical stress responses in humans. Sci Rep 2015;5:13865. 

  175. Fregni F, Boggio PS, Nitsche MA, Rigonatti SP, Pascual-Leone A. Cognitive effects of repeated sessions of transcranial direct current stimulation in patients with depression. Depress Anxiety 2006;23:482-484. 

  176. Boggio PS, Rigonatti SP, Ribeiro RB, Myczkowski ML, Nitsche MA, Pascual-Leone A, et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol 2008;11:249-254. 

  177. Loo CK, Alonzo A, Martin D, Mitchell PB, Galvez V, Sachdev P. Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry 2012;200:52-59. 

  178. Palm U, Schiller C, Fintescu Z, Obermeier M, Keeser D, Reisinger E, et al. Transcranial direct current stimulation in treatment resistant depression: a randomized double-blind, placebo-controlled study. Brain Stimul 2012;5:242-251. 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로